Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study
2022 · Drugs in R&D · 42 citations
https://doi.org/10.1007/s40268-022-00396-1
A
Alessandra Narcisi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
247
Papers
2.3K
Citations
27
h-index
75
i10-index
Alessandra Narcisi is an academic researcher from Humanitas University. The author has contributed to research in topics: Psoriasis: Treatment and Pathogenesis & Dermatology and Skin Diseases & Autoimmune Bullous Skin Diseases. The author has an h-index of 27, co-authored 210 publications.
ORCID: 0000-0002-1938-8581Papers by this author
worksManagement of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus
2024 · Dermatology and Therapy · 29 citations
https://doi.org/10.1007/s13555-024-01135-x
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma
2022 · Melanoma Research · 13 citations
https://doi.org/10.1097/cmr.0000000000000875
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis
2024 · Dermatology and Therapy · 13 citations
https://doi.org/10.1007/s13555-024-01185-1
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis)
2024 · Journal of Dermatological Treatment · 12 citations
https://doi.org/10.1080/09546634.2024.2393376
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)
2024 · Dermatology and Therapy · 10 citations
https://doi.org/10.1007/s13555-024-01182-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat